Lantheus Holdings Shares Outstanding 2013-2024 | LNTH
Lantheus Holdings shares outstanding history from 2013 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Lantheus Holdings shares outstanding for the quarter ending December 31, 2024 were 0.072B, a 2.01% increase year-over-year.
- Lantheus Holdings 2024 shares outstanding were 0.072B, a 2.01% increase from 2023.
- Lantheus Holdings 2023 shares outstanding were 0.07B, a 0.61% decline from 2022.
- Lantheus Holdings 2022 shares outstanding were 0.071B, a 4.72% increase from 2021.
| Lantheus Holdings Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 72 |
| 2023 | 70 |
| 2022 | 71 |
| 2021 | 67 |
| 2020 | 54 |
| 2019 | 40 |
| 2018 | 40 |
| 2017 | 39 |
| 2016 | 33 |
| 2015 | 24 |
| 2014 | 18 |
| 2013 | 18 |
| 2012 | 50 |
| Lantheus Holdings Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-12-31 | 72 |
| 2024-09-30 | 73 |
| 2024-06-30 | 71 |
| 2024-03-31 | 70 |
| 2023-12-31 | 70 |
| 2023-09-30 | 70 |
| 2023-06-30 | 71 |
| 2023-03-31 | 68 |
| 2022-12-31 | 71 |
| 2022-09-30 | 71 |
| 2022-06-30 | 71 |
| 2022-03-31 | 70 |
| 2021-12-31 | 67 |
| 2021-09-30 | 68 |
| 2021-06-30 | 68 |
| 2021-03-31 | 68 |
| 2020-12-31 | 54 |
| 2020-09-30 | 67 |
| 2020-06-30 | 43 |
| 2020-03-31 | 40 |
| 2019-12-31 | 40 |
| 2019-09-30 | 40 |
| 2019-06-30 | 40 |
| 2019-03-31 | 40 |
| 2018-12-31 | 40 |
| 2018-09-30 | 39 |
| 2018-06-30 | 39 |
| 2018-03-31 | 39 |
| 2017-12-31 | 39 |
| 2017-09-30 | 39 |
| 2017-06-30 | 39 |
| 2017-03-31 | 39 |
| 2016-12-31 | 33 |
| 2016-09-30 | 32 |
| 2016-06-30 | 31 |
| 2016-03-31 | 30 |
| 2015-12-31 | 24 |
| 2015-09-30 | 31 |
| 2015-06-30 | 19 |
| 2015-03-31 | 18 |
| 2014-12-31 | |
| 2014-09-30 | 18 |
| 2014-06-30 | 18 |
| 2013-12-31 | |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $7.447B | $1.534B |
| Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. | |||